drugset / Trial / NCT01452126

Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach

NCT01452126 ↗

Phase 2 Terminated 49 enrolled University of New Mexico
NaSingle-groupTriple-blind

Summary

This is a dose finding study to identify the minimum effective anesthetic concentration (MEAC) of ropivacaine to produce insensate body parts sufficient for surgery in supraclavicular and infraclavicular approaches to the brachial plexus, parasacral and popliteal approaches to the sciatic nerve, femoral nerve and transversus abdominis plane (TAP) blocks in adults.

Timeline

Start
2011-06
Primary completion
2011-09
Completion
2011-09

Outcome

Outcome not reported

Stopped: “Departure of principal investigator”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified — Other

Indications

No indication recorded.